DSpace Kyoto University
Japanese | English 

Kyoto University Research Information Repository >
Graduate School of Pharmaceutical Sciences >
Journal Articles >

Access count of this item: 3

Please use this identifier to cite or link to this item: http://hdl.handle.net/2433/218209

Full text link:

File Description SizeFormat
s13041-016-0282-7.pdf1.91 MBAdobe PDFView/Open
Title: Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging.
Authors: Yagishita, Sosuke
Suzuki, Seiya
Yoshikawa, Keisuke
Iida, Keiko
Hirata, Ayako
Suzuki, Masahiko
Takashima, Akihiko
Maruyama, Kei
Hirasawa, Akira kyouindb researcher_resolver
Awaji, Takeo
Author's alias: 平澤, 明
Keywords: Sleep-disordered breathing
Intermittent hypoxia
Gene ontology-based microarray analysis
Alzheimer disease
Issue Date: 5-Jan-2017
Publisher: Springer Nature
Journal title: Molecular brain
Volume: 10
Issue: 2
Abstract: Sleep-disordered breathing produces cognitive impairments, and is possibly associated with Alzheimer disease (AD). Intermittent hypoxia treatment (IHT), an experimental model for sleep-disordered breathing, results in cognitive impairments in animals via unknown mechanisms. Here, we exposed mice to IHT protocols, and performed biochemical analyses and microarray analyses regarding their hippocampal samples. In particular, we performed gene ontology (GO)-based microarray analysis to elucidate effects of IHT on hippocampal functioning, which were compared with the effects of various previously-reported experimental conditions on that (ref. Gene Expression Omnibus, The National Center for Biotechnology Information). Our microarray analyses revealed that IHT and aging shared alterations in some common GO, which were also observed with kainic acid treatment, Dicer ablation, or moderate glutamate excess. Mapping the altered genes using the Kyoto Encyclopedia of Genes and Genomes PATHWAY database indicated that IHT and aging affected several pathways including "MAPK signaling pathway", "PI3K-Akt signaling pathway", and "glutamatergic synapse". Consistent with the gene analyses, in vivo analyses revealed that IHT increased phosphorylated tau, reflecting an imbalance of kinases and/or phosphatases, and reduced proteins relevant to glutamatergic synapses. In addition, IHT increased phosphorylated p70 S6 kinase, indicating involvement of the mammalian target of rapamycin signaling pathway. Furthermore, IHT mice demonstrated hyperactivity in Y-maze tests, which was also observed in AD models. We obtained important data or something from the massive amount of microarray data, and confirmed the validity by in vivo analyses: the IHT-induced cognitive impairment may be partially explained by the fact that IHT increases phosphorylated tau via biological processes common to aging. Moreover, as aging is a major risk factor for AD, IHT is a novel model for investigating the pathological processes contributing to AD onset.
Rights: © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
URI: http://hdl.handle.net/2433/218209
DOI(Published Version): 10.1186/s13041-016-0282-7
PubMed ID: 28057021
Appears in Collections:Journal Articles

Export to RefWorks

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Powered by DSpace 3.2.0 and JAIRO Crawler-List version 1.1
All items in KURENAI are protected by original copyright, with all rights reserved, unless otherwise indicated.